FHTX Foghorn Therapeutics4.85+0.16 (+3.4%)
FHTX Foghorn Therapeutics17.00+5.01 (+41.8%)
Premarket Gainer
FHTX Foghorn Therapeutics11.99+0.49+4.3%
Premarket:16.07+4.08 (+34.0%)
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control Platform
PRNewswireMon, 13-Dec 6:00 AM